New perspectives for use of gamma-glutamyltranspeptidase in clinical enzymes tests
https://doi.org/10.24884/1607-4181-2016-23-2-6-11
Abstract
Gamma-glutamyltranspeptidase (GGTP), isolated from a variety of sources from microorganisms to mammals, including human blood and organs, has been studied sufficiently detailed, which allowed to take a fresh look at the role of this enzyme in cellular metabolism, the pathogenesis of several diseases and its application in clinical medicine. Evidences in favor of use of GGTP as reliable marker to forecast cardiovascular diseases, and complications of type 2 diabetes of a metabolic syndrome are accumulated.
About the Author
L. A. Alexandrova
Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
References
1. Александрова Л. А., Жлоба А. А., Блашко Э. Л. и др. Метаболизм аминотиолов и антиоксидантный статус крыс в условиях односторонней ишемии почки // Профилакт. и клин. мед. – 2010. – № 2. – С. 103–105.
2. Александрова Л. А., Филиппова Н. А., Субботина Т. Ф. и др. Оценка проявлений окислительно-нитрозильного стресса при системных заболеваниях соединительной ткани // Ученые записки СПбГМУ им. акад. И. П. Павлова. – 2016. – Т. 23. – № 1. – С. 26–29.
3. Калинина Е. В., Чернов Н. Н., Новичкова М. Д. Роль глутатиона, глутатионтрансферазы и глутаредоксина в регуляции редокс-зависимых процессов раза и глутаредоксин // Успехи биолог. химии. – 2014. – Т. 54. – С. 299–348.
4. Кулинский В. И., Колесниченко Л. С. Система глутатиона. II Другие ферменты, тиол-дисульфидный обмен, воспаление и иммунитет, функции // Биомед. химия. – 2009. – Т. 55. – Вып. 4. – С. 365–379.
5. Belcastro E., Franzini M., Cianchetti S. Monocytes/macro phages activation contributes to г-gamma-glutamyltransferase accumulation inside atherosclerotic plaques // J. Transl. Med. – 2015. – Vol. 13. – P. 325.
6. Castellano I., Merlino A. Gamma Glutamyl Transpeptida ses: Structure and Function. – Heidelberg: Springer, 2013. doi: 10.1007/978-3-0348-0682-4.
7. Chung M. C., Malatesta P., Bosquesi P L. et. al. Advances in Drug Design Based on the Amino Acid Approach: Taurine Ana logues for the Treatment of CNS Diseases // Pharmaceuticals. – 2012. – Vol. 5. – P. 1128–1146. doi:10.3390/ph5101128.
8. Corti A., Franzini M., Paolicchi A., Pompella A. Gamma glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting // Anticancer. Res. – 2010. – Vol. 30. – P. 1169–1181.
9. Dahboul F., Leroy P., Maguin Gate K. et al. Endothelial gamma glutamyltransferase contributes to the vasorelaxant effect of S-Nitrosoglutathione in rat aorta // PLoS ONE. – 2012. – Vol. 7. – P. e43190. doi: 10.1371/journal.pone.0043190.
10. Dominici S., Paolicchi A., Lorenzini E. et al. Gammaglutamyltransferase-dependent prooxidant reactions: a factor in multiple processes // Biofactors. – Vol. 17. – P. 187–198.
11. Fornaciari I., Fierabracci V., Corti A. et al. Gamma-Glutamyltransferase Fractions in Human Plasma and Bile: Characteristic and Biogenesis // PLoS ONE. – 2014. – Vol. 9. – P. e88532. doi: 10.1371/journal.pone.0088532.
12. Fraser A., Harris R., Sattar N. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women’s Heart and Health Study and Meta-Analysis // Arterioscler. Thromb. Vasc. Biol. – 2007. – № 27. – Р. 2729–2735. doi: 10.1161/ATVBAHA.107.152298.
13. Fraser A., Harris R., Sattar N. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women’s Heart and Health Study and meta-analysis // Diabetes Care. – 2009. – № 32. – Р. 741–750. doi: 10.2337/dc08-1870.
14. Franzini M., Ottaviano V., Fierabracci V. Fractions of plasma gamma-glutamyltransferase in healthy individuals: reference values // Clin. Chim. Acta. – 2008. – Vol. 395. – P. 188–189.
15. Franzini M., Corti A., Martinelli B. et al. г-Glutamyltransferase activity in human atherosclerotic plaques – Biochemical similarities with the circulating enzyme // Atherosclerosis. – 2009. – Vol. 202. – Is. 1. – P. 119–127.
16. Goldberg D. M. Rev. Clin. Lab. Sci. – 1980. – Vol. 121. – Р. 1–58.
17. Hanigan M. Gamma Glutamyl Transpeptidase: Redox Regulation and Drug Resistance // Adv. Cancer Res. – 2014. – Vol. 122. – P. 103–141. doi: 10.1016/B978-0-12-420117-0.00003-7.
18. Hiramatsu K., Asaba Y., Takeshita S. et al. Overexpression of Glutamyltransferase in Transgenic Mice Accelerates Bone Resorption and Causes Osteoporosis // Endocrinology. – 2007. – Vol. 148. – P. 2708–2715.
19. Ho C. C. The association between serum GGT concentration and diabetic peripheral polyneuropathy in type 2 diabetic patients // Korean diabetes J. – 2010. – Vol. 34. – P. 111–118.
20. Hogg. N., Singh J., Konorev E. et al. S-Nitrosoglutathione as a substrate for c-glutamyl transpeptidase // Biochem. J. – 1997. – Vol. 323. – P. 477–481.
21. Hou X., Zeng F., Wu S. A fluorescent assay for γ - glutamyltranspeptidase via aggregation induced emission and its applications in real samples // Biosens Bioelectron. – 2016. – Vol. 85. – P. 317–323. doi: 10.1016/j.bios.2016.05.036.
22. Kim D., Lee D. H., Jacobs D. R. et al. Serum gammaglutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors // Diabetic. Medicine. – 2005. – Vol. 22. – P. 1134–1140.
23. Koenig G., Seneff S. Gamma-glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk //Hindawi Publishing Corporation Disease Markers. – 2015. – Article ID 818570. – 18 pages. URL: http://dx. doi.org/10.1155/2015/818570.
24. Lee D. H., Gross M. D., Jacobs D. R. Jr. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study // Clin. Chem. – 2004. – Vol. 50. – P. 582–528.
25. Lee D. H., Jacobs D. R. Association between serum gammaglutamyltransferase and C reactive protein // Atheroscle rosis. – 2005. – Vol. 178. – P. 327–330.
26. Lee D. S., Evans J. C., Robins S. J. et al. Gamma glutamyltransferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart study // Arterioscler. Thromb. Vasc. Biol. – 2007. – Vol. 27. – P. 127–33.
27. Lee S., Sung E., Chang Y. et al. Elevated Serum Gamma-Glutamyltransferase Is a Strong Marker of Insulin Resistance in Obese Children // International Journ. of Endocrinology. – 2013. – Article ID 578693. – 6 pages. URL: http://dx. doi. org/10.1155/2013/578693.
28. Levasseur R., Barrios R., Elefteriou F. et al. Reversible ske letal abnormalities in gamma-glutamyltranspeptidase deficient mice // Endocrinology. – 2003. – Vol. 144. – P. 2761–2764.
29. Moon D. O., Kim B. Y., Jang J. H. et al. K RAS transfor mation in prostate epithelial cell overcomes H2O2 induced apoptosis via upregulation of gamma glutamyltransferase 2 // Toxicol. In Vitro. – 2012. – Vol. 3. – P. 429–434. doi: 10.1016/j.tiv.2012.01.013.
30. Nakajima M., Watanabe B., Han L. et al. Glutathione analogous peptidyl phosphorus esters as mechanism based inhibitors of γ-glutamyl transpeptidase for probing cysteinyl-glycine binding site // Bioorg Med. Chem. – 2014. – Vol. 22. – P. 1176–1194. doi: 10.1016/j.bmc.
31. Niida S., Kawahara M., Ishizuka Y. et al. Gamma glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor // J. Biol. Chem. – 2004. – Vol. 279. – № 7. – P. 5752–5756.
32. Onur S., Niklowitz P., Jacobs G. et al. Ubiquinol reduces gamma-glutamyltransferase as a marker of oxidative stress in humans // Researchю Notes. – 2014. – Vol. 7. – P. 427–436.
33. Paolicchi A., Minotti G., Tonarelli P. et al. Gamma-glutamyltranspeptidase-dependent iron reduction and LDL oxidation – a potential mechanism in atherosclerosis // J. Investig. Med. – 1999. – Vol. 47. – P. 151–160.
34. Pompella A., Visvikis A., Paolicchi A. et al. The changing faces of glutathione, a cellular protagonist // Biochem. Pharmacol. – 2003. – Vol. 66. –№ 8. – Р. 1499–1503.
35. Ristoff E., Larsson A. Inborn errors in the metabolism of glutathione // Orphanet Journ. of Rare Diseases. – 2007. – Vol. 2. – P. 16. doi: 10.1186/1750-1172-2-16.
36. Strasak A. M. Pfeiffer M. F., Klenk J. et al. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women // Int. J. Cancer. – 2008. – Vol. 123. – P. 1902–1906.
37. Sweiry J., Sastret J. Vifia J. A role for γ-glutamyltranspeptidase and the amino acid transport system xc- in cystine transport by a human pancreatic duct cell line // Journ. of Physiology. – 1995. – Vol. 485. – № 1. – P. 167–177.
38. Uys J. D., Mulholland P. J., Townsend D. M. Glutathione and redox signaling in substance abuse // Biomed Pharmacother. – 2014. – Vol. 68. – P. 799–807.
39. West M. B., Chen Y., Wickham S., et al. Novel insights into eukaryotic г-glutamyltranspeptidase 1 from the crystal structure of the glutamate bound human enzyme // J. Biol. Chem. – 2013. – Vol. 288. – P. 31902–31913.
40. Yilmaz M. I., Turgut F., Kanbay M. Serum gamma glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease // Int. Urol. Nephrol. – 2013. – Vol. 45. – P. 1071–1078. Doi: 10.01007/s11255-012-0354-2.
Review
For citations:
Alexandrova L.A. New perspectives for use of gamma-glutamyltranspeptidase in clinical enzymes tests. The Scientific Notes of the Pavlov University. 2016;23(2):6-11. (In Russ.) https://doi.org/10.24884/1607-4181-2016-23-2-6-11
Views:
1040
Email this article 